The Technical AnalystExchange: PNK Industry: Medical Devices
H-CYTE, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.50% $0.995
America/New_York / 7 jul 2023 @ 15:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 0.625 mill |
| EPS: | -15.51 |
| P/E: | -0.0642 |
| Earnings Date: | Aug 09, 2023 |
| SharesOutstanding: | 0.628 mill |
| Avg Daily Volume: | 0.0008 mill |
| RATING 2023-07-07 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Sell | |
| P/E: | Neutral | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 1/22 | 2/22 | 3/22 | 4/22 | 1/23 | 3/23 | |
| Revenue | n/a | n/a | n/a | |||
| Gr.Profit | n/a | |||||
| Ebit | n/a | |||||
| Asset | n/a | |||||
| Debt | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.0642 | sector: PE -11.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -0.0642 | industry: PE -6.92 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.764 - 1.236 ( +/- 23.60%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-01-16 | Wagner Todd R | Sell | 303 107 000 | SERIES A PREFERRED STOCK |
| 2024-01-16 | Wagner Todd R | Buy | 303 107 | COMMON STOCK |
| 2024-01-16 | Farrior J Rex Iii | Sell | 13 168 000 | SERIES A PREFERRED STOCK |
| 2024-01-16 | Farrior J Rex Iii | Buy | 13 168 | COMMON STOCK |
| 2022-03-21 | Lynch Frederick J | Sell | 8 321 785 | STOCK PURCHASE WARRANTS |
| INSIDER POWER |
|---|
| -99.80 |
| Last 90 transactions |
| Buy: 833 204 294 | Sell: 379 884 747 |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.995 (-0.50% ) |
| Volume | 0.0003 mill |
| Avg. Vol. | 0.0008 mill |
| % of Avg. Vol | 40.83 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For HCYT
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
HCYT
H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.